Total Antioxidant Capacity (TAC) is a biomarker often used in order to investigate oxidative stress in many pathological conditions. Saliva and urine can be collected noninvasively and represent attractive diagnostic fluids for detecting biomarkers of various pathological conditions. The reviewed case-control and intervention studies that measured salivary or urinary TAC revealed that diseases, antioxidant foods, or supplements and age, gender, and lifestyle factors influenced salivary or urinary TAC. Salivary and urinary TAC were particularly affected by oral or renal status, respectively, as well as by infection; therefore these factors must be taken into account in both case-control and intervention studies. Furthermore, some considerations on sample collection and normalization strategies could be made. In particular, unstimulated saliva could be the better approach to measure salivary TAC, whereas 24 h or spontaneous urine collection should be chosen on the basis of the study outcome and of the creatinine clearance. Finally, the uric acid-independent TAC could be the better approach to evaluate red-ox status of body, in particular after nutritional interventions and in diseases associated with hyperuricaemia.
1. Introduction
Oxidative stress, defined as the imbalance between Reactive Oxygen Species (ROS) production and antioxidant defense inside human organism, is a risk factor playing a significant pathogenetic role for noncommunicable diseases [1]. A nonphysiological ROS production originates either by xenobiotics or by endogenous sources [2], such as the respiratory burst [3]. Synergistic interactions between antioxidants, in part involving antioxidant regeneration, must be taken into account in order to properly assess antioxidant status in vivo. Total Antioxidant Capacity (TAC), defined as the moles of oxidants neutralized by one litre of solution, is a biomarker measuring the antioxidant potential of body fluids [4]. Several reviews described the various assays commonly used for the measurement of TAC [5–8] and a good correlation between the results obtained with different methods was found [9, 10]. Salivary and urinary collections are simple and noninvasive and this is the reason why TAC of saliva or urine has led to increasing interest. It has been suggested that saliva could constitute a first line of defense against free radical-mediated oxidative stress [11], whereas the composition of urine reflects the continuously changing environment of the body, which is affected, among other factors, by diet and in particular by polyphenol metabolites excreted in urine [12].
We aimed to review case-control and intervention studies that measured salivary [13–138] or urinary [138–179] TAC.
2. Infection and Oral and Renal Status
Saliva and urine are particularly affected by oral or renal status, respectively, as well as by infection; therefore the relationships of salivary and urinary TAC with these conditions have been investigated in many studies (Table 1). Urinary TAC increased during urinary tract infection [148, 149], while decreased levels of salivary TAC were observed during H. pylori [130] and HIV [98, 112] infections and after a single consumption of enterococci containing Bryndza cheese [63]. The latter temporally affected the composition of oral microbiota [63].
HAART: highly active antiretroviral therapy; TAC: total antioxidant capacity; ↑: increase; ↓: decrease; ↔: unchanged.
On the contrary, dental caries, one of the most common infectious diseases worldwide, was associated with higher salivary TAC (Table 1). Therefore, the relationship between infection and TAC depends on the type and on the site of infection.
On the other hand, oxidative stress is implicated in the pathogenesis of many oral diseases and meta-analysis results showed that TAC levels from peripheral blood samples were significantly different between periodontitis (PD) patients and healthy subjects, suggesting that chronic periodontitis is associated with systemic oxidative stress in human bodies [180]. In agreement with this finding, lower values of salivary TAC were found in PD patients versus healthy subjects in 66.7% of the studies (Table 1). When increased salivary TAC levels were observed, it has been suggested that this increase may represent an adaptive response to oxidative stress in PD [115]. Dental hygiene procedures and scaling and root planing increased salivary TAC in 100% of the studies conducted on healthy subjects with caries and in 50% of the studies on patients with PD (Table 1). Therefore, the antioxidant status in saliva is related to both oral hygiene and periodontal status.
On the other hand, 66.7% of the studies that have investigated the salivary TAC in more serious oral diseases, including recurrent aphthous stomatitis (RAS) (the most common oral ulcerative condition) [36, 88], stem cell transplantation- (SCT-) related salivary gland injury due to graft versus host disease (GVHD) [92], oral mucositis induced by high-dose therapy of melphalan in myeloma patients treated with autologous SCT [22], cleft lip and palate [17], oral premalignant lesions (leukoplakia, lichen planus, and erythroplakia) [13–15, 23, 29, 49, 83, 113, 128], and oral cancers [14, 24], found decreased levels of salivary TAC in these patients (Table 1). Furthermore, salivary TAC was decreased also in patients with peri-implant disease [81] and in children undergoing fixed orthodontic therapy [54].
Concerning renal status, decreased levels of urinary TAC have been reported in renal diseases including secondary (induced by hypertension and diabetes) and primary renal disease, chronic and acute renal failure, and shockwave lithotripsy- (SWL-) induced acute kidney injury (Table 1).
Decreased urinary TAC has been reported 120 minutes after SWL in both patients with kidneys stone and controls [158], but others reported that SWL did not change urinary TAC measured in the 24-h urine [179]. On the contrary, urinary TAC was higher in childhood urolithiasis and was associated with hyperuricosuria [154].
Chronic renal failure is often treated with peritoneal dialysis and chronic renal failure patients undergoing dialysis are characterized by decreased urinary TAC [142]. However, both increased and decreased salivary TAC was found in these patients [30, 31, 86] (Table 1), probably due to the hyperuricaemia. Kidney transplantation is the treatment of choice for most patients with end-stage renal disease and it has been suggested that urinary biomarkers of oxidative stress could be useful in the assessment of kidney quality before transplantation, which is needed to predict recipient outcomes and to optimize management and allocation of the allograft [181]. In particular, TAC was found to be significantly lower in donor urine for kidneys from poor cadaveric donors, based on clinical impression or renal transplant outcome, compared to urinary TAC of living related donors and good cadaveric donors [173, 174]. On the other hand, increased urinary TAC was found in patients with delayed graft function, but not with early graft function [174].
3. Systemic Diseases
Oxidative stress is associated with the metabolic syndrome, a cluster of cardiovascular risk factors including dyslipidemia, abnormal glucose tolerance, hypertension, and obesity [182]. Despite the antioxidant effect of uric acid (UA), hyperuricaemia is associated with obesity and insulin resistance [183] and has been proposed as a component of the metabolic syndrome [184, 185].
Contrasting results came from the studies that investigated salivary TAC in subjects with at least one of the metabolic syndrome symptoms (Table 2).
Pregnant women with diabetes were found to have increased salivary TAC, but also markedly increased indexes of caries activity [119]. Besides the authors [119] found increased Lactobacillus and Streptococcus species in saliva of pregnant women with diabetes having systemic complications as compared to healthy individuals and other patients. However, increase in salivary TAC was observed also in obese subjects with hyperuricaemia [50] and in obese children despite their good oral hygiene status [56]. While rasburicase infusion decreased salivary TAC [50], intravenous N-acetylcysteine failed to prevent renal dysfunction and oxidative stress after contrast media administration during percutaneous coronary interventions [144] (Table 2). On the other hand, only hypertensive patients in treatment with metoprolol had lower salivary TAC compared to controls [46] (Table 2).
Salivary or urinary TAC was studied also in other diseases, such as cancer, neuropsychiatric disorders, congenital and genetic diseases, and immune mediated and inflammatory diseases (Table 2).
Urinary TAC was decreased in bladder cancer [165] and in nonsmokers with lung cancer [152], but not in smokers with lung cancer. Decreased salivary TAC was observed in patients with squamous cell carcinoma of head and neck [74] and with brain tumor [118], but increased salivary TAC was reported in acute lymphoblastic leukemia (ALL) children [59] (Table 2). Only children with more than 2 weeks of chemotherapy had decreased levels of salivary TAC [59].
Increased levels of salivary TAC were found in patients with neurological disorders and tube-feeding [42], whereas decreased levels were reported in cerebral palsy [117], intractable epilepsy [111], and autistic children [105]. Also urinary TAC levels were lower in autistic compared to healthy children [150, 167].
On the other hand, case-control studies on congenital or genetic diseases such as Down syndrome [43, 116] and cystic fibrosis [82] reported conflicting results on salivary TAC (Table 2). Besides, Campos et al. [146] found increased and decreased levels of urinary TAC in children and adults with Down syndrome, respectively (Table 2). On the contrary, urinary TAC resulted in a good marker of oxidative stress in patients with inborn errors of metabolism (IEM), such as maple syrup urine disease (MSUD), propionic aciduria (PA), methylmalonic aciduria (MMA), 3-hydroxy-3-methylglutaric aciduria (HMGA), and ornithine transcarbamylase deficiency (OTC), both before and after treatment (Table 2).
On the other hand, salivary TAC was lower in asthma [58], Crohn’s disease [106], multiple sclerosis [65, 135], and Sjögren’s syndrome [109] patients compared to healthy individuals (Table 2), but neither corticosteroid therapy, in multiple sclerosis patients [65], nor continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSAS) improved salivary TAC [38, 123]. Furthermore, increased salivary TAC levels were found in chronic obstructive pulmonary disease (COPD) [132] and in juvenile idiopathic arthritis (JIA) [33]. Children with JIA, whether treated or not treated with anti-tumor necrosis factor- (TNF-) α agents (Infliximab or Etanercept), had higher salivary TAC and the increase of the active patients was nearly two times higher than that of nonactive patients [33]. Increased salivary TAC levels were found also in pre- and postsurgical patients, where surgical procedures, involving stress such as extended general anaesthesia and a long presurgical fasting period, may cause systemic inflammation and oxidative stress [126]. Increased salivary TAC was also observed in Regional Pain Syndrome type I [48], whereas decreased salivary TAC levels were reported in temporomandibular disorders [108].
4. Nutritional and Supplement Interventions
Although body possesses a sophisticated and cooperative array of endogenous antioxidant defenses, dietary consumption of antioxidant-rich foods may lower the risk of noncommunicable diseases, by increasing TAC. In fact, 70% of the interventions with plant foods or supplements conducted on subjects characterized by oxidative stress conditions such as cardiovascular risk factors (smoking, hypercholesterolemia, metabolic syndrome, hyperlipidemia, and hypertension) or with pathologies reported an increase of plasma/serum TAC [186]. In the studies that investigated the effect of dietary or supplementation interventions on salivary or urinary TAC (Table 3), volunteers were prevalently healthy; however, in some studies, overweight (OW) [164] or elderly [94, 143, 147, 153] subjects, smokers [25], or patients with PD [137] or dialyzed [142] were enrolled. A review of 41 interventions, from 29 studies, has been performed (Table 3). Of these interventions, 18 regard a single ingestion (bolus) and the other 23 were related to repeated supplementations.
Caffeinated or alcoholic antioxidant beverages increased salivary TAC in 50% and urinary TAC in 40% of the interventions. In particular, green tea (GT) consumption for 4 or 12 weeks increased salivary TAC in laboratory workers and elderly subjects [94, 120], whereas it did not affect salivary TAC of Taekwondo (TKD) athletes after training [80]. Besides, Benzie et al. [141] found a significant correlation between urinary FRAP values and urinary total phenolic concentrations after GT consumption. Red wine bolus consumption did not change salivary TAC [127] but increased urinary TAC in elderly women [147]. After a single or 2 weeks of consumption of green or black coffee urinary TAC did not change [138, 168].
On the other hand, walnuts [160, 166] increased urinary TAC both after 4 weeks and after a single consumption and cocoa increased urinary TAC at 6–12 h after intake concomitantly with the excretion of epicatechin urinary metabolites [170] (Table 3).
Concerning fruit, juices, and vegetables, only Zare Javid et al. [137] investigated the effect of fruits, vegetables, and whole grains (3 and 6 months) consumption on salivary TAC of PD patients and did not find any change in this marker. Only one study reported decreased urinary TAC levels after a single consumption of blackberry juices [157]. On the contrary, urinary TAC increased after bolus consumption of spinach [147], strawberries [147], Jerte Valley cherry [153], and a fruit based drink (86% of a mix of apple, grape, blueberry and pomegranate juices and grape skin, grape seed, and green tea extracts) ingested during a high fat meal (HFM) [164]. In the same postprandial study, a less antioxidant fruit based drink (63% of a mix of pineapple, black currant, and plum juices) during HFM did not affect urinary TAC, a well as plasma TAC [164]. Also grape juice consumption for 5 days increased urinary TAC [155], whereas tomato juice consumption for 2 weeks did not [161]. The same study found increased urinary TAC levels when tomato juice was supplemented with vitamin C (870 mg/L) fortification [161]. Vitamin C (250 mg) with vitamin E (400 i.u.) supplementation for 8 weeks increased urinary TAC in dialyzed patients [142] and vitamin C in bolus administration increased urinary TAC in elderly women (1250 mg) [147] and salivary TAC in healthy subjects (250 mg) [64]. On the contrary neither vitamin C after 3 weeks (500 mg) of consumption in smokers [25] nor 90 days of astaxanthin supplementation in trained male soccer players in preexercise conditions [27] changed salivary TAC. Conversely, red wine extract administration caused a marked rise in salivary TAC, within 30 min, and the same treatment raised also salivary polyphenol concentration [127]. Helbig et al. [159] reported the same increase in urinary TAC versus baseline with both control bread and bread enriched with black currant press residue (4 weeks). Besides, urinary TAC was unchanged after 21 days consumption of a dried fruit and vegetable extracts fortified with antioxidants [176], after 2 weeks of Pycnogenol (200 mg/day) supplementation [175] and after 24 days of administration of an antioxidant mixture containing vitamin E, beta-carotene, ascorbic acid, selenium, alpha-lipoic acid, N-acetyl 1-cysteine, catechin, lutein, and lycopene [171]. On the contrary, ganoderma lucidum (Lingzhi, woody mushroom) supplements increased urinary TAC both in bolus and in repeated administration [177, 178].
Concerning other dietary interventions, a low fat diet did not affect salivary TAC compared to a high fat diet [32] and a HFM did not affect urinary TAC [164]. On the contrary, a fish diet (8 oz/week of salmon) for 4 weeks [160] and the consumption of tryptophan-enriched cereals for 1 week [143] increased urinary TAC.
5. Age, Gender, and lifestyle Factors
Age and gender differences were observed in oxidative stress markers in plasma [187]. It was found that salivary TAC increased with the age of the children with caries [60], as well as during aging [62, 69]. On the contrary, others reported that salivary TAC was higher in younger subjects [73] and negative correlations with age were found for urinary TAC [146]. Women had significantly lower salivary TAC than men [79, 110, 114]. In this context Kawamoto et al. [66] reported decreased levels of salivary TAC during the ovulatory phase compared to follicular phase in women with PD, but not in healthy women. TAC was negatively correlated with bacterial counts during the ovulatory phase, but not during the follicular phase [66]. Besides, salivary TAC was lower during uncomplicated pregnancy [70] and in osteoporotic subjects compared to age-matched healthy women [133].
Apart from age, gender, diseases, and dietary habit, also lifestyle factors could affect salivary and urinary TAC. Within lifestyle factors, many studies investigated the effect of exercise and smoking habit on salivary or urinary TAC (Table 4).
Life-style factors.
References
Factor
Salivary TACpercentage (n°)
Urinary TACpercentage (n°)
[21, 80, 85, 134, 140]
Exercise
↓ 75% (3/4)↑ 25% (1/4)
↓ 100% (1/1)
[32, 35, 41, 53, 71, 77, 93, 132, 136, 138, 145]
Smoking habit
↑ 20% (2/10)↔ 50% (5/10)↓ 30% (3/10)
↔ 100% (1/1)
[102]
Alcohol dependence
↓ 100% (1/1)
[51, 139]
Occupational exposure to toxicants
↓ 100% (1/1)
↑ 100% (1/1)
[18, 20, 57, 67]
Cell phone and watching TV
↑ 75% (3/4)↓ 25% (1/4)
TAC: Total Antioxidant Capacity.
In agreement with the well-known reduction of antioxidant defenses after physical stress, strong correlation was found between the variations of salivary and plasma TAC during the training season in triathletes [134]. Both 2 hr TKD training session and 1 hr exhaustive aerobic dance exercise decreased salivary TAC [21, 80]. Besides also urinary TAC decreased after 3 hours or more of TKD training camp/d for 5–8 days [140]. Only a study found increased salivary TAC in older adults with PD who performed Tai Chi during a period of 6 months; however this increase was accompanied by a statistically significant decrease in the Periodontal Disease Index (PDI) [85].
More conflicting are results on smoking habit; higher, lower, or nonsignificant different levels of salivary TAC have been found in smokers compared to nonsmokers, whereas no significant differences were found in urinary TAC between smokers and nonsmokers (Table 4).
On the contrary, alcohol-dependent subjects showed significantly lower TAC in blood and saliva as compared to those in the controls and the alcohol withdrawal caused an increase in the TAC to near-control values [102].
Decreased levels of salivary TAC were found also in workers subjected to occupational exposure to nonferrous metal mine conditions [51], whereas exposure to trichloroethylene increased urinary TAC [139].
Although there was no statistically significant effect of cell phone talking time on the salivary TAC, the latter progressively increased with time and reached maximum at 30 min, probably due to exposure to radio frequency radiation [67]. However, both increased [57] and decreased [18] levels of salivary TAC in mobile phone users were found.
On the other hand, it has been observed that salivary TAC was affected by emotional and psychological factors [20]. In particular, watching a cheerful comical video for 30 min increased salivary TAC [20].
6. Methodological Issues
Despite the differences between the assays [8], concordant results were found in the majority of the cases between the results obtained when two different methods (Trolox Equivalent Antioxidant Capacity (TEAC), Ferric Reducing Antioxidant Potential (FRAP), Oxygen Radical Antioxidant Capacity (ORAC), Total-radical Trapping Antioxidant Parameter (TRAP), or enzyme-linked immunosorbent assay (ELISA) colorimetric kit) were used in the same study to measure salivary or urinary TAC (Figure 1(a)).
Concordat results between two different methods used in the same study to measure salivary or urinary TAC (a). Concordant results between unstimulated and stimulated saliva samples analyzed in the same study (b). References [22, 24, 34, 38, 50, 62, 64, 65, 67, 72, 78, 81, 111, 127, 135, 137, 161, 166, 175, 188–190].
In particular, although FRAP was significantly lower in multiple sclerosis patients, whereas no significant difference in salivary TEAC between patients and controls was observed [65], the authors pointed out that their study had some limitations, such as the low number of patients included, the variability of the clinical status, and the different treatment of patients. Therefore, method choice does not seem to be a critical point for salivary TAC measure. On the contrary, major concerns came from saliva collection (Figure 1(b)).
Saliva sampling has been improved by cotton and polypropylene Salivette collection systems, but the latter altered the determination of some markers [188]. It has been reported that in samples collected using the cotton Salivette TAC was comparable, but higher thiobarbituric acid reacting substances (TBARS) concentrations were determined compared with unstimulated saliva [188].
In healthy subjects values were higher under stimulated conditions for saliva flow and were higher under unstimulated conditions with respect to TAC and UA [189]. When TAC was examined with respect to flow rate, a significantly lower rate of antioxidant production was noted in patients with PD compared with controls for unstimulated saliva but not for stimulated saliva [34]. Besides, a significant decrease in UA and TAC was observed in unstimulated saliva as well as a significant increase in all antioxidants examined in stimulated saliva of systemic sclerosis women with normal salivary flow rate as compared to the healthy controls [135].
Nagler et al. [190] examined the correlation between the levels of various salivary antioxidant components and the TAC in whole saliva in comparison with those in saliva secreted specifically from the major salivary glands: the parotid and the submandibular/sublingual (Sm_Sl) glands. While the secretory IgA and lysozyme concentrations were similar in parotid and Sm_Sl saliva, the authors [190] found higher levels of the various antioxidant parameters (antioxidant enzymes, UA and TAC) in the parotid saliva as compared with the Sm_Sl saliva, especially under resting condition. Under resting condition parotid saliva was the major source of salivary antioxidants, especially of UA [190]. After stimulation (i.e., eating), the various parameters of antioxidants of parotid saliva were considerably reduced, in light of the well-reported “dilution effect” that follows stimulation. In addition, fluids by nonglandular sources contributed to the possible dilution of the whole saliva, after meal. Therefore, unstimulated saliva with and without flow rate normalization could be the better approaches to measure salivary TAC.
Also urine can be more or less diluted, complicating the evaluation of parameters in spontaneous urine. Particularly after physical stress [140] more concentrated urine is to be expected due to sweating. In order to obviate this problem and provided that the creatinine excretion is relatively constant over 24 h, the mean creatinine excretion can serve as a reference for the measured values of excretion. Generally, an average creatinine excretion of 1 g/24 h is assumed [140]. However, it must be taken into consideration that age, sex, muscle mass, and diet all have an influence on creatinine excretion [191]. Although analyzing 24 h urine collection would have been preferable in case-control studies, it was logistically impossible in some cases. On the other hand, 24 h urine collection could not appreciate the increase in TAC due to intervention with polyphenol-rich foods, considering the rate of elimination of polyphenols [12]. Therefore, 24 h or spontaneous urine collection should be chosen on the basis of the study outcome and of the creatinine clearance.
7. Uric Acid-Independent TAC versus TAC
UA is a powerful scavenger of free radicals and provides 60–80% of TAC in plasma [192, 193]. It has been also reported that TAC of both plasma and urine is mainly related to the UA concentration of the samples [194]. Besides, UA contributes approximately 70% of the salivary TAC [89], with the antioxidant role of the ascorbic acid being secondary [89] and correlation between concentrations of UA in both saliva and plasma points to the latter as the origin of salivary UA [71, 190]. According to this hypothesis, when salivary or urinary TAC, UA, and plasma or serum TAC were measured in the same study, it turned out that there was a clear accordance between UA concentration and TAC, as well as between salivary or urinary TAC and plasma or serum TAC in case-control studies (Figure 2(a)). Furthermore, rasburicase i.v. infusion in obese subjects with hyperuricaemia caused a marked decrease in both plasma and saliva TAC values [50].
Concordant results between salivary or urinary TAC and UA levels or plasma TAC in case-control (a) or antioxidant/nutritional intervention (b) studies. References [17, 19, 21–24, 26, 28–31, 34, 37, 38, 40–44, 48–51, 55, 57, 61, 62, 65, 71, 77, 78, 81, 82, 86–89, 91, 92, 95–97, 102, 106–111, 119, 126, 132–136, 140–142, 144, 146, 147, 150, 154, 157, 159–162, 164, 166, 171, 175–178].
Increase in serum UA levels can be due to increased intake of dietary purines, alcohol and fructose [195], impaired renal function and renal microvascular disease, which can increase UA production and/or decrease UA clearance [196], and hyperinsulinemia, which increases renal UA reabsorption [197]. In particular, the plasma level of UA is regulated by renal function [162]. However, although urine from renal disease patients had more proteins and UA compared to controls, urinary TAC from acute renal failure patients did not correlate with UA [162]. Furthermore, contrasting results came from patients with severe chronic renal failure (CRF) (dialytic) without diabetes and severe CRF (dialytic) with diabetes [30]. In severe-CRF patients without diabetes, median TAC and UA levels decreased following dialysis, whereas in severe-CRF patients with diabetes, median TAC increased following dialysis while median UA decreased [30].
Although UA in urine samples constitutes about 75% of urinary TAC [140], the composition of urine is unpredictable, reflecting the continuously changing environment of the body, which is affected, among other factors, by diet [162]. In fact, only in 44% (4/9) of the interventions with antioxidant foods, beverages or supplements urinary TAC was related to UA (Figure 1(b)). These findings are probably due to the fact that low molecular weight antioxidants, such as polyphenols, are cleared from the blood by kidney [12]. The only study that [137] investigated the effect of fruits, vegetables, and whole grains consumption on both salivary and plasma TAC did not find any change in salivary TAC, despite the increase in plasma TAC.
In order to avoid the UA interference, methods for UA-independent TAC have been proposed, by using the uricase reaction, in both plasma and urine [198], or by using the corrected TAC, the calculated parameter that represents the fraction of circulating antioxidants after the elimination of the interference of UA [140, 199].
Similar calculated urinary TAC has been proposed by Campos et al. [146]. Authors suggested that TAC-UA/Cr could provide more reliable information about the antioxidant status, at least in Down syndrome, because children had higher TAC/Cr and UA/Cr, whereas levels of TAC-UA/Cr of adult patients were lower compared to healthy subjects.
On the contrary, uricase methods could be biased by the generation of H2O2 during the action of uricase [200]. Therefore, the calculated corrected TAC-UA could be the better approach.
8. Conclusion
The reviewed case-control and intervention studies that measured salivary or urinary TAC revealed that these markers can be useful in the evaluation of the antioxidant status of the body taking into account some factors. First of all, salivary and urinary TAC were particularly affected by oral or renal status, respectively, as well as by infection (Table 1); therefore these factors could bias results in some studies [66, 85, 119]. Second, samples collection (Figure 1) and normalization strategies should be chosen on the basis of the type of biological fluid, of the study outcome, and of the creatinine clearance. Again, TAC is related to both UA (Figure 2) and nutritional antioxidant levels in biological fluids [127, 141, 147, 170]. From that, the UA-independent TAC could be the better approach to evaluate red-ox status of body both after nutritional interventions and in diseases associated with hyperuricaemia. Finally, TAC is sensitive also to the endogenous antioxidant response induced by some pathological and environmental conditions [20, 33, 48, 57, 59, 67, 115, 126, 132, 139, 142].
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
WagnerK.-H.BrathH.A global view on the development of non communicable diseases201254supplementS38S4110.1016/j.ypmed.2011.11.0122-s2.0-84860847145Limón-PachecoJ.GonsebattM. E.The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress20096741-213714710.1016/j.mrgentox.2008.09.0152-s2.0-61649088812ValkoM.LeibfritzD.MoncolJ.CroninM. T. D.MazurM.TelserJ.Free radicals and antioxidants in normal physiological functions and human disease2007391448410.1016/j.biocel.2006.07.0012-s2.0-33749986298NikiE.Assessment of antioxidant capacity in vitro and in vivo201049450351510.1016/j.freeradbiomed.2010.04.0162-s2.0-77954536067BartoszG.Non-enzymatic antioxidant capacity assays: limitations of use in biomedicine201044771172010.3109/107157610037581142-s2.0-77953347825KnasmüllerS.NersesyanA.MišíkM.GernerC.MikulitsW.EhrlichV.HoelzlC.SzakmaryA.WagnerK.-H.Use of conventional and -omics based methods for health claims of dietary antioxidants: a critical overview200899supplement 1ES3ES5210.1017/S0007114508965752PinchukI.ShovalH.DotanY.LichtenbergD.Evaluation of antioxidants: scope, limitations and relevance of assays2012165663864710.1016/j.chemphyslip.2012.05.0032-s2.0-84864746518DilisV.TrichopoulouA.Assessment of antioxidants in foods and biological samples: a short critique201061544144810.3109/096374809033862342-s2.0-77954944875CaoG.PriorR. L.Comparison of different analytical methods for assessing total antioxidant capacity of human serum1998446, part 1130913152-s2.0-0031745637CamposC.GuzmánR.López-FernándezE.CasadoÁ.Evaluation of the copper(II) reduction assay using bathocuproinedisulfonic acid disodium salt for the total antioxidant capacity assessment: the CUPRAC-BCS assay20093921374410.1016/j.ab.2009.05.0242-s2.0-67649372477GreabuM.BattinoM.MohoraM.TotanA.SpinuT.TotanC.DidilescuA.DuţaC.Could constitute saliva the first line of defence against oxidative stress?20074522092132-s2.0-42449089043Pérez-JiménezJ.HubertJ.HooperL.CassidyA.ManachC.WilliamsonG.ScalbertA.Urinary metabolites as biomarkers of polyphenol intake in humans: a systematic review201092480180910.3945/ajcn.2010.299242-s2.0-78049443809AbdolsamadiH.RafieianN.GoodarziM. T.FeradmalJ.DavoodiP.JazayeriM.TaghaviZ.HoseyniS.Ahmadi-MotamayelF.Levels of salivary antioxidant vitamins and lipid peroxidation in patients with oral lichen planus and healthy individuals2014502586210.4068/cmj.2014.50.2.58Agha-HosseiniF.Mirzaii-DizgahI.FarmanbarN.AbdollahiM.Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma2012411073674010.1111/j.1600-0714.2012.01172.x2-s2.0-84868341190Agha-HosseiniF.Mirzaii-DizgahI.MikailiS.AbdollahiM.Increased salivary lipid peroxidation in human subjects with oral lichen planus20097424625010.1111/j.1601-5037.2009.00365.x2-s2.0-77953118633Ahmadi-MotamayelF.GoodarziM.-T.HendiS.-S.KasraeiS.MoghimbeigiA.Total antioxidant capacity of saliva and dental caries2013184e553e5562-s2.0-84903505746AizenbudD.Peri-FrontY.NaglerR. M.Salivary analysis and antioxidants in cleft lip and palate children200853651752210.1016/j.archoralbio.2007.12.0062-s2.0-43049176182Arbabi-KalatiF.SalimiS.Vaziry-RabieeA.NoraeeiM.Effect of mobile phone usage time on total antioxidant capacity of saliva and salivary immunoglobulin A20144344804842-s2.0-84900024046AstaneieF.AfshariM.MojtahediA.MostafalouS.ZamaniM. J.LarijaniB.AbdollahiM.Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients200536437638110.1016/j.arcmed.2005.03.0072-s2.0-20444388662AtsumiT.FujisawaS.NakabayashiY.KawaraiT.YasuiT.TonosakiK.Pleasant feeling from watching a comical video enhances free radical-scavenging capacity in human whole saliva200456337737910.1016/S0022-3999(03)00064-32-s2.0-1842575654AtsumiT.IwakuraI.KashiwagiY.FujisawaS.UehaT.Free radical scavenging activity in the nonenzymatic fraction of human saliva: a simple DPPH assay showing the effect of physical exercise19991453754610.1089/ars.1999.1.4-5372-s2.0-0033301902AviviI.AvrahamS.Koren-MichowitzM.ZuckermanT.AvivA.OfranY.BenyaminiN.NaglerA.RoweJ. M.NaglerR. M.Oral integrity and salivary profile in myeloma patients undergoing high-dose therapy followed by autologous SCT2009431080180610.1038/bmt.2008.3872-s2.0-67349263413AziziA.FarshchiF.Comparison of salivary and plasma antioxidant levels in lichen planus patients and healthy subjects201241752452610.1111/j.1600-0714.2012.01138.x2-s2.0-84864393431BaharG.FeinmesserR.ShpitzerT.PopovtzerA.NaglerR. M.Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile20071091545910.1002/cncr.223862-s2.0-33846331272BakhtiariS.TaheriJ. B.BakhshiM.MortazaviH.HoseiniA. S.DastjerdiE. V.AzimiS.Effect of vitamin C on salivary total antioxidant capacity in smokers2012114104510492-s2.0-84871350018BaltacıoğluE.YuvaP.AydınG.AlverA.KahramanC.KarabulutE.AkalinF. A.Lipid peroxidation levels and total oxidant/antioxidant status in serum and saliva from patients with chronic and aggressive periodontitis. Oxidative stress index: a new biomarker for periodontal disease?201485101432144110.1902/jop.2014.1306542-s2.0-84907494875BaralicI.AndjelkovicM.DjordjevicB.DikicN.RadivojevicN.Suzin-ZivkovicV.Radojevic-SkodricS.PejicS.Effect of astaxanthin supplementation on salivary IgA, oxidative stress, and inflammation in young soccer players20152015978376110.1155/2015/783761BaserU.Gamsiz-IsikH.CifcibasiE.AdemogluE.YalcinF.Plasma and salivary total antioxidant capacity in healthy controls compared with aggressive and chronic periodontitis patients2015367856861BattinoM.GreabuM.TotanA.BullonP.BucurA.TovaruS.MohoraM.DidilescuA.ParlatescuI.SpinuT.TotanC.Oxidative stress markers in oral lichen planus200833430131010.1002/biof.55203304062-s2.0-67649756000Ben-ZviI.GreenY.NakhoulF.KanterY.NaglerR. M.Effects of diabetes mellitus, chronic renal failure and hemodialysis on serum and salivary antioxidant status20071053c114c12010.1159/0000983202-s2.0-33846804012BibiG.GreenY.NaglerR. M.Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis200812216417010.1111/j.1744-9987.2008.00564.x2-s2.0-41749103316BoguckaM.GiebułtowiczJ.ZawadaK.WroczyńskiP.WierzchowskiJ.PietrzakM.PiekarczykP.RomanowskaK.The oxidation status of ALDH3A1 in human saliva and its correlation with antioxidant capacity measured by orac method20096654774822-s2.0-70350515213BrikR.RosenI.SavulescuD.BorovoiI.GavishM.NaglerR.Salivary antioxidants and metalloproteinases in juvenile idiopathic arthritis2010163-412212810.2119/molmed.2009.000962-s2.0-77649175994BrockG. R.ButterworthC. J.MatthewsJ. B.ChappleI. L. C.Local and systemic total antioxidant capacity in periodontitis and health200431751552110.1111/j.1600-051X.2004.00509.x2-s2.0-3142519983BuduneliN.KardeşlerL.IşikH.WillisC. S.IIIHawkinsS. I.KinaneD. F.ScottD. A.Effects of smoking and gingival inflammation on salivary antioxidant capacity200633315916410.1111/j.1600-051X.2006.00892.x2-s2.0-33645029192ÇağlayanF.MilogluÖ.AltunO.ErelÖ.YilmazA. B.Oxidative stress and myeloperoxidase levels in saliva of patients with recurrent aphthous stomatitis200814870070410.1111/j.1601-0825.2008.01466.x2-s2.0-54049143867CanakciV.YildirimA.CanakciC. F.EltasA.CicekY.CanakcitH.Total antioxidant capacity and antioxidant enzymes in serum, saliva, and gingival crevicular fluid of preeclamptic women with and without periodontal disease20077881602161110.1902/jop.2007.0604692-s2.0-34548094537CelecP.HodosyJ.BehuliakM.PálffyR.GardlíkR.HalčákL.MucskaI.Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure201216239339810.1007/s11325-011-0510-42-s2.0-84861481726CelecováV.KamodyováN.TóthováĽ.KúdelaM.CelecP.Salivary markers of oxidative stress are related to age and oral health in adult non-smokers201342326326610.1111/jop.120082-s2.0-84874740165ChappleI. L. C.MasonG. I.GarnerI.MatthewsJ. B.ThorpeG. H.MaxwellS. R. J.WhiteheadT. P.Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid199734, part 44124212-s2.0-0030800233CharalabopoulosK.AssimakopoulosD.KarkabounasS.DanielidisV.KiortsisD.EvangelouA.Effects of cigarette smoking on the antioxidant defence in young healthy male volunteers2005591253010.1111/j.1742-1241.2004.00340.x2-s2.0-13844313933Cunha-CorreiaA. S.NetoA. H.PereiraA. F.AguiarS. M. H. C. Á.NakamuneA. C. D. M. S.Enteral nutrition feeding alters antioxidant activity in unstimulated whole saliva composition of patients with neurological disorders20143561209121510.1016/j.ridd.2014.03.0032-s2.0-84897106302de SousaM. C.VieiraR. B.Dos SantosD. S.CarvalhoC. A. T.CamargoS. E. A.ManciniM. N. G.de OliveiraL. D.Antioxidants and biomarkers of oxidative damage in the saliva of patients with Down's syndrome201560460060510.1016/j.archoralbio.2014.09.0132-s2.0-84921480920Diab-LadkiR.PellatB.ChahineR.Decrease in the total antioxidant activity of saliva in patients with periodontal diseases20037210310710.1007/s00784-003-0208-52-s2.0-0142125306DiSilvestroR. A.DiSilvestroD. J.DiSilvestroD. J.Pomegranate extract mouth rinsing effects on saliva measures relevant to gingivitis risk200923811231127DjukićL.RoganovićJ.BrajovićM. D.BokonjićD.StojićD.The effects of anti-hypertensives and type 2 diabetes on salivary flow and total antioxidant capacity201521561962510.1111/odi.12325DodwadR.BetigeriA. V.PreetiB. P.Estimation of total antioxidant capacity levels in saliva of caries-free and caries-active children201121172010.4103/0976-237x.79296EisenbergE.ShtahlS.GellerR.ReznickA. Z.SharfO.RavbinovichM.ErenreichA.NaglerR. M.Serum and salivary oxidative analysis in Complex Regional Pain Syndrome2008138122623210.1016/j.pain.2008.04.0192-s2.0-47249113835ErgunS.TroşalaŞ. C.WarnakulasuriyaS.ÖzelS.ÖnalA. E.OfluoǧluD.GüvenY.TanyeriH.Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus201140428629310.1111/j.1600-0714.2010.00955.x2-s2.0-79952828775FabbriniE.SerafiniM.Colic BaricI.HazenS. L.KleinS.Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects201463397698110.2337/db13-13962-s2.0-84894444173GreabuM.DidilescuA.PuiuL.MiricescuD.TotanA.Salivary antioxidant biomarkers in non-ferrous metals mine workers—a pilot study201241649049310.1111/j.1600-0714.2012.01131.x2-s2.0-84863494707GreabuM.PuriceM.TotanA.SpînuT.TotanC.Salivary cortisol-marker of stress response to different dental treatment200644149592-s2.0-33847098358GuentschA.PreshawP. M.Bremer-StreckS.KlingerG.GlockmannE.SiguschB. W.Lipid peroxidation and antioxidant activity in saliva of periodontitis patients: effect of smoking and periodontal treatment200812434535210.1007/s00784-008-0202-z2-s2.0-55749110056GulerC.ToyE.OzturkF.GunesD.KarabulutA. B.OtluO.Evaluation of salivary total oxidant-antioxidant status and DNA damage of children undergoing fixed orthodontic therapy201585223924410.2319/110113-798.1GümüşP.BuduneliN.ÇetinkalpŞ.HawkinsS. I.RenaudD.KinaneD. F.ScottD. A.Salivary antioxidants in patients with type 1 or 2 diabetes and inflammatory periodontal disease: a case-control study20098091440144610.1902/jop.2009.0901592-s2.0-69949162034GunjalliG.KumarK. N.JainS. K.ReddyS. K.ShaviG. R.AjagannanavarS. L.Total salivary anti-oxidant levels, dental development and oral health status in childhood obesity2014646367HamzanyY.FeinmesserR.ShpitzerT.MizrachiA.HillyO.HodR.BaharG.OtradnovI.GavishM.NaglerR. M.Is human saliva an indicator of the adverse health effects of using mobile phones?201318662262710.1089/ars.2012.47512-s2.0-84872475213HegdeA. M.RajK.ShettyS.Relation of caries status on the salivary total antioxidant levels in asthmatic children201234402405HegdeA. M.JoshiS.RaiK.ShettyS.Evaluation of oral hygiene status, salivary characteristics and dental caries experience in Acute Lymphoblastic Leukemic (ALL) children201135331932310.17796/jcpd.35.3.u5kx28q33m7608342-s2.0-79959437612HegdeA. M.RaiK.PadmanabhanV.Total antioxidant capacity of saliva and its relation with early childhood caries and rampant caries200933323123410.17796/jcpd.33.3.c730518021m560772-s2.0-67651085564HegdeM. N.HegdeN. D.AshokA.ShettyS.Evaluation of total antioxidant capacity of saliva and serum in caries-free and caries-active adults: an in-vivo study201324216416710.4103/0970-9290.1166702-s2.0-84884375854HershkovichO.ShafatI.NaglerR. M.Age-related changes in salivary antioxidant profile: possible implications for oral cancer200762436136610.1093/gerona/62.4.3612-s2.0-34250326326KamodyováN.MinárikG.HodosyJ.CelecP.Single consumption of Bryndza cheese temporarily affects oral microbiota and salivary markers of oxidative stress201469571672410.1007/s00284-014-0649-xKamodyováN.TóthováL.CelecP.Salivary markers of oxidative stress and antioxidant status: influence of external factors201334531332110.3233/dma-1309752-s2.0-84878843963KarlíkM.ValkovičP.HančinováV.KrížováL.TóthováĽ.CelecP.Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis2015481-2242810.1016/j.clinbiochem.2014.09.0232-s2.0-84920275439KawamotoA.SuganoN.MotohashiM.MatsumotoS.ItoK.Relationship between salivary antioxidant capacity and phases of the menstrual cycle201247559359810.1111/j.1600-0765.2012.01471.x2-s2.0-84865561426KhalilA. M.Abu KhadraK. M.AljaberiA. M.GagaaM. H.IssaH. S.Assessment of oxidant/antioxidant status in saliva of cell phone users2014332929710.3109/15368378.2013.7838552-s2.0-84900417033KimS.-C.KimO.-S.KimO.-J.KimY.-J.ChungH.-J.Antioxidant profile of whole saliva after scaling and root planing in periodontal disease201040416417110.5051/jpis.2010.40.4.1642-s2.0-80051489100KohenR.TiroshO.KopolovichK.The reductive capacity index of saliva obtained from donors of various ages199227216116810.1016/0531-5565(92)90040-72-s2.0-0026651641KolarzykE.PietrzyckaA.StępniewskiM.ŁyszczarzJ.MendykA.Ostachowska-GąsiorA.Micronutrients and macronutrients and parameters of antioxidative ability in saliva of women: inhabitants of Krakow (Poland) in the course of uncomplicated singleton pregnancy20061141–3738410.1385/bter:114:1:732-s2.0-33846261212KondakovaI.LissiE. A.PizarroM.Total reactive antioxidant potential in human saliva of smokers and non-smokers19994769119202-s2.0-0033062904KrawczykD.BłaszczakJ.BorowiczJ.Mielnik-BłaszczakM.Life style and risk of development of dental caries in a population of adolescents201421357658010.5604/12321966.11206052-s2.0-84907986687KrawczykD.Sikorska-JaroszyńskaM. H. J.Mielnik-BłaszczakM.PasternakK.KapećE.SztankeM.Dental caries and total antioxidant status of unstimulated mixed whole saliva in patients aged 16–23 years201257116316810.2478/v10039-012-0015-92-s2.0-84865155272KumarA.PantM. C.SinghH. S.KhandelwalS.Determinants of oxidative stress and DNA damage (8-OhdG) in squamous cell carcinoma of head and neck201249330931510.4103/0019-509x.1044992-s2.0-84871630397KumarD.PandeyR. K.AgrawalD.AgrawalD.An estimation and evaluation of total antioxidant capacity of saliva in children with severe early childhood caries201121645946410.1111/j.1365-263x.2011.01154.x2-s2.0-80053570607Kurhańska-FlisykowskaA.ŁojewskiW.Wyganowska-SwiatkowskaM.Effectiveness of Emdogain in the periodontal treatment2012691010461048KurkuH.KacmazM.KisaU.DoganO.CaglayanO.Acute and chronic impact of smoking on salivary and serum total antioxidant capacity2015652164169LeiteM. F.FerreiraN. F. D.ShitsukaC. D. W. M.LimaA. M.MasuyamaM. M.Sant'AnnaG. R.YamagutiP. M.PolotowT. G.De BarrosM. P.Effect of topical application of fluoride gel NaF 2% on enzymatic and non-enzymatic antioxidant parameters of saliva201257663063510.1016/j.archoralbio.2011.10.0222-s2.0-84861589714LettrichováI.TóthováL.HodosyJ.BehuliakM.CelecP.Variability of salivary markers of oxidative stress and antioxidant status in young healthy individuals201510.1179/1351000215y.0000000009LinS.-P.LiC.-Y.SuzukiK.ChangC.-K.ChouK.-M.FangS.-H.Green tea consumption after intense taekwondo training enhances salivary defense factors and antibacterial capacity201491e8758010.1371/journal.pone.00875802-s2.0-84900408056LiskmannS.VihalemmT.SalumO.ZilmerK.FischerK.ZilmerM.Characterization of the antioxidant profile of human saliva in peri-implant health and disease2007181273310.1111/j.1600-0501.2006.01296.x2-s2.0-33846243283LivnatG.BenturL.KuzmisnskyE.NaglerR. M.Salivary profile and oxidative stress in children and adolescents with cystic fibrosis2010391162110.1111/j.1600-0714.2009.00813.x2-s2.0-76249123390Lopez-JornetP.Martinez-CanovasA.Pons-FusterA.Salivary biomarkers of oxidative stress and quality of life in patients with oral lichen planus201414365465910.1111/ggi.121532-s2.0-84904967526MahjoubS.GhasempourM.GharageA.BijaniA.MasrourroudsariJ.Comparison of total antioxidant capacity in saliva of children with severe early childhood caries and caries-free children201448427127510.1159/0003555812-s2.0-84893669732Mendoza-NúñezV. M.Hernández-MonjarazB.Santiago-OsorioE.Betancourt-RuleJ. M.Ruiz-RamosM.Tai chi exercise increases SOD activity and total antioxidant status in saliva and is linked to an improvement of periodontal disease in the elderly20142014660385310.1155/2014/6038532-s2.0-84899580853MeucciE.LittarruC.DeliG.LucianiG.TazzaL.LittarruG. P.Antioxidant status and dialysis: plasma and saliva antioxidant activity in patients with fluctuating urate levels199829536737610.1080/107157698003004112-s2.0-0032419626MiricescuD.TotanA.CalenicB.MocanuB.DidilescuA.MohoraM.SpinuT.GreabuM.Salivary biomarkers: relationship between oxidative stress and alveolar bone loss in chronic periodontitis2014721424710.3109/00016357.2013.7956592-s2.0-84890902633Momen-BeitollahiJ.MansourianA.Momen-HeraviF.AmanlouM.ObradovS.SahebjameeM.Assessment of salivary and serum antioxidant status in patients with recurrent aphthous stomatitis2010154e557e56110.4317/medoral.15.e5572-s2.0-77954612686MooreS.CalderK. A. C.MillerN. J.Rice-EvansC. A.Antioxidant activity of saliva and periodontal disease199421641742510.3109/107157694090565942-s2.0-0028535110MuchandiS.WalimbeH.Ahmed BijleM. N.NankarM.ChaturvediS.KarekarP.PatilS. G.Comparative evaluation and correlation of salivary total antioxidant capacity and salivary pH in caries-free and severe early childhood caries children201516323423710.5005/jp-journals-10024-1667MussaviraS.DharmalingamM.SukumaranB. O.Salivary glucose and antioxidant defense markers in type II diabetes mellitus201545114114710.3906/sag-1306-1162-s2.0-84920016569NaglerR.Barness-HadarL.LiebaM.NaglerA.Salivary antioxidant capacity in graft versus host disease200624326927710.1080/073579006006340132-s2.0-33646476835NaglerR. M.Altered salivary profile in heavy smokers and its possible connection to oral cancer20072242742802-s2.0-39149094020NarotzkiB.ReznickA. Z.MitkiT.AizenbudD.LevyY.Green tea drinking improves erythrocytes and saliva oxidative status in the elderly2014832253310.1007/5584_2014_82-s2.0-84914166116NovakovićN.CakićS.TodorovićT.RaicevićBA.DozićI.PetrovićV.PerunovićN.GostovićS. S.SretenovićJ. K.ColakE.Antioxidative status of saliva before and after non-surgical periodontal treatment20131413-4163168NovakovicN.TodorovicT.RakicM.MilinkovicI.DozicI.JankovicS.AleksicZ.CakicS.Salivary antioxidants as periodontal biomarkers in evaluation of tissue status and treatment outcome201449112913610.1111/jre.120882-s2.0-84891829383NunesL. A. S.BrenzikoferR.MacedoD. V.Reference intervals for saliva analytes collected by a standardized method in a physically active population20114417-181440144410.1016/j.clinbiochem.2011.09.0122-s2.0-81555205711PadmanabhanV.RaiK.HegdeA.ShettyS.Total antioxidant capacity of saliva in children with HIV201034434735010.17796/jcpd.34.4.475137x4n8kj67652-s2.0-77955967195PandeyP.ReddyN. V.RaoV. A.SaxenaA.ChaudharyC. P.Estimation of salivary flow rate, pH, buffer capacity, calcium, total protein content and total antioxidant capacity in relation to dental caries severity, age and gender201565, supplement 1S65S7110.4103/0976-237x.152943PendyalaG.ThomasB.JoshiS.Periodontitis, diabetes mellitus, and the lopsided redox balance: a unifying axis201317333834410.4103/0972-124x.1156612-s2.0-84882324076PendyalaG.ThomasB.JoshiS. R.Evaluation of total antioxidant capacity of saliva in type 2 diabetic patients with and without periodontal disease: a case-control study201351515710.4103/1947-2714.1062082-s2.0-84872856758PeterN.KevinK. J.ShivashankaraA. R.Effect of alcohol withdrawl on glutathione S-transferase, total antioxidant capacity and amylase in blood and saliva of alcohol-dependent males20137579780010.7860/JCDR/2013/4658.29422-s2.0-84877104058PrabhakarA. R.DodawadR.OsR.Evaluation of flow rate, pH, buffering capacity, calcium, total protein and total antioxidant levels of saliva in caries free and caries active children—an in vivo study20092191210.5005/jp-journals-10005-1034PreethiB. P.ReshmaD.AnandP.Evaluation of flow rate, pH, buffering capacity, calcium, total proteins and total antioxidant capacity levels of saliva in caries free and caries active children: an in vivo study201025442542810.1007/s12291-010-0062-62-s2.0-84865001143RaiK.HegdeA. M.JoseN.Salivary antioxidants and oral health in children with autism20125781116112010.1016/j.archoralbio.2012.03.0062-s2.0-84864489768RezaieA.GhorbaniF.EshghtorkA.ZamaniM. J.DehghanG.TaghaviB.NikfarS.MohammadiradA.DaryaniN. E.AbdollahiM.Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-beta 1 in relation to disease activity in Crohn's disease patients2006109111012210.1196/annals.1378.0602-s2.0-33947609783ReznickA. Z.ShehadehN.ShafirY.NaglerR. M.Free radicals related effects and antioxidants in saliva and serum of adolescents with Type 1 diabetes mellitus200651864064810.1016/j.archoralbio.2006.02.0042-s2.0-33746327762Rodríguez de SotilloD.VellyA. M.HadleyM.FrictonJ. R.Evidence of oxidative stress in temporomandibular disorders: a pilot study2011381072272810.1111/j.1365-2842.2011.02216.x2-s2.0-80052559909Ron'G. I.ShmelevaL. T.KleinA. V.EIuI.Lipid peroxidation and the status of the basal membrane of the acinar cells in the minor salivary glands of patients with Sjögren's syndrome199222326SculleyD. V.Langley-EvansS. C.Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation2003105216717210.1042/CS200300312-s2.0-0042090583ShaharE.AttiasU.SavulescuD.GenizinJ.GavishM.NaglerR.Oxidative stress, metalloproteinase and LDH in children with intractable and non-intractable epilepsy as reflected in salivary analysis2014108111712410.1016/j.eplepsyres.2013.10.0032-s2.0-84890787515ShaharE.PollackS.KedemE.HassounG.NaglerR.Effect of HAART on salivary composition and oxidative profile in HIV-infected patients20086544745110.2174/1570162087858612122-s2.0-53849117787ShirzadA.PouramirM.SeyedmajidiM.JenabianN.BijaniA.MotallebnejadM.Salivary total antioxidant capacity and lipid peroxidation in patients with erosive oral lichen planus2014813539ShirzaiyM.AnsariS. M.DehghanJ. H.GhaeniS. H.Total anti-oxidant capacity of saliva in chronic periodontitis patients before and after periodontal treatment20141228172176SuH.GornitskyM.VellyA. M.YuH.BenarrochM.SchipperH. M.Salivary DNA, lipid, and protein oxidation in nonsmokers with periodontal disease200946791492110.1016/j.freeradbiomed.2009.01.0082-s2.0-61449175649SubramaniamP.Girish BabuK.Mohan DasL.Assessment of salivary total antioxidant levels and oral health status in children with Down syndrome201434419320010.1111/scd.120542-s2.0-84904060777SubramaniamP.Mohan DasL.BabuK. L.Assessment of salivary total antioxidant levels and oral health status in children with cerebral palsy201438323523910.17796/jcpd.38.3.tv26g158q73432872-s2.0-84905021379SumaH.PrabhuK.ShenoyR. P.AnnaswamyR.RaoS.RaoA.Estimation of salivary protein thiols and total antioxidant power of saliva in brain tumor patients20106327828110.4103/0973-1482.733572-s2.0-78650116771SurdackaA.CiężkaE.Pioruńska-StolzmannM.Wender-OzegowskaE.KorybalskaK.KawkaE.KaczmarekE.WitowskiJ.Relation of salivary antioxidant status and cytokine levels to clinical parameters of oral health in pregnant women with diabetes201156542843610.1016/j.archoralbio.2010.11.0052-s2.0-79954417413TavakolH. S.AkramR.AzamS.NahidZ.Protective effects of green tea on antioxidative biomarkers in chemical laboratory workers201531986286710.1177/0748233713484659TotanA.MiricescuD.ParlatescuI.MohoraM.GreabuM.Possible salivary and serum biomarkers for oral lichen planus201590755255810.3109/10520295.2015.1016115TóthováL.CelecováV.CelecP.Salivary markers of oxidative stress and their relation to periodontal and dental status in children201334191510.3233/dma-2012-009432-s2.0-84872309393TóthováL.HodosyJ.MucskaI.CelecP.Salivary markers of oxidative stress in patients with obstructive sleep apnea treated with continuous positive airway pressure201418356357010.1007/s11325-013-0919-z2-s2.0-84889041795TulunogluÖ.DemirtasS.TulunogluI.Total antioxidant levels of saliva in children related to caries, age, and gender200616318619110.1111/j.1365-263X.2006.00733.x2-s2.0-33645450686UberosJ.AlarcónJ. A.PeñalverM. A.Molina-CarballoA.RuizM.GonzálezE.CastejonJ.Muñoz-HoyosA.Influence of the antioxidant content of saliva on dental caries in an at-risk community20082052, article E510.1038/sj.bdj.2008.5202-s2.0-48749115235UllmannY.KleinY.SavulescuD.BorovoiI.EgoziD.GavishM.NaglerR.Salivary monitoring related to major surgery201040121074108010.1111/j.1365-2362.2010.02355.x2-s2.0-78649440241VaroniE. M.VitaliniS.ContinoD.LodiG.SimonettiP.GardanaC.SardellaA.CarrassiA.IritiM.Effects of red wine intake on human salivary antiradical capacity and total polyphenol content20135828929410.1016/j.fct.2013.04.0472-s2.0-84879323501VlkováB.StankoP.MinárikG.TóthováĽ.SzemesT.BaňasováL.NovotňákováD.HodosyJ.CelecP.Salivary markers of oxidative stress in patients with oral premalignant lesions201257121651165610.1016/j.archoralbio.2012.09.0032-s2.0-84870245088VorsC.DraiJ.GabertL.PineauG.LavilleM.VidalH.GuichardE.MichalskiM.FeronG.Salivary composition in obese vs normal-weight subjects: towards a role in postprandial lipid metabolism?20153991425142810.1038/ijo.2015.71WnukM.MyszkaA.LewinskaA.TokarzI.SolarskaK.BartoszG.Helicobacter pylori cagA gene polymorphism affects the total antioxidant capacity of human saliva2010151535710.1111/j.1523-5378.2009.00731.x2-s2.0-74349113743YangP. S.HuangW. C.ChenS. Y.ChenC. H.LeeC. Y.LinC. T.HuangY. K.Scaling-stimulated salivary antioxidant changes and oral-health behavior in an evaluation of periodontal treatment outcomes20142014881467110.1155/2014/814671YiglaM.BerkovichY.NaglerR. M.Oxidative stress indices in COPD—broncho-alveolar lavage and salivary analysis2007521364310.1016/j.archoralbio.2006.08.0022-s2.0-33845293459YousefzadehG.LarijaniB.MohammadiradA.HeshmatR.DehghanG.RahimiR.AbdollahiM.Determination of oxidative stress status and concentration of TGF-β1 in the blood and saliva of osteoporotic subjects2006109114215010.1196/annals.1378.0622-s2.0-33947600578YoussefH.GroussardC.MacheferG.MinellaO.CouillardA.KnightJ.Gratas-DelamarcheA.Comparison of total antioxidant capacity of salivary, capillary and venous samplings: interest of the salivary total antioxidant capacity on triathletes during training season20084845225292-s2.0-57749187238ZalewskaA.KnaśM.Gińdzieńska-SieśkiewiczE.WaszkiewiczN.KlimiukA.LitwinK.SierakowskiS.WaszkielD.Salivary antioxidants in patients with systemic sclerosis2014431616810.1111/jop.120842-s2.0-84891830171ZappacostaB.PersichilliS.De SoleP.MordenteA.GiardinaB.Effect of smoking one cigarette on antioxidant metabolites in the saliva of healthy smokers199944648548810.1016/s0003-9969(99)00025-42-s2.0-0033153363Zare JavidA.SealC. J.HeasmanP.MoynihanP. J.Impact of a customised dietary intervention on antioxidant status, dietary intakes and periodontal indices in patients with adult periodontitis201427652353210.1111/jhn.121842-s2.0-84889020786ZiobroA.BartoszG.A comparison of the total antioxidant capacity of some human body fluid2003824154192-s2.0-0038266638AbusogluS.CelikH. T.TutkunE.YilmazH.SerdarM. A.BalC. D.YildirimkayaM.AvcikucukM.8-Hydroxydeoxyguanosine as a useful marker for determining the severity of trichloroethylene exposure201469318018610.1080/19338244.2013.7637612-s2.0-84892888973BenkhaiH.LemanskiS.BelowH.HeidenJ. U.BelowE.LademannJ.BornewasserM.BalzT.ChudaskeC.KramerA.Can physical stress be measured in urine using the parameter antioxidative potential?201052Doc0310.3205/dgkh000146BenzieI. F. F.SzetoY. T.StrainJ. J.TomlinsonB.Consumption of green tea causes rapid increase in plasma antioxidant power in humans1999341838710.1207/S15327914NC3401122-s2.0-0032838254BoudourisG.VerginadisI. I.SimosY. V.ZouridakisA.RagosV.KarkabounasS. C.EvangelouA. M.Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and e supplementation20134541137114410.1007/s11255-012-0334-62-s2.0-84881475126BravoR.MatitoS.CuberoJ.ParedesS. D.FrancoL.RiveroM.RodriguezA. B.BarrigaC.Tryptophan-enriched cereal intake improves nocturnal sleep, melatonin, serotonin, and total antioxidant capacity levels and mood in elderly humans20133541277128510.1007/s11357-012-9419-52-s2.0-84891717197BuyukhatipogluH.SezenY.YildizA.BasM.KirhanI.UlasT.TuranM. N.TaskinA.AksoyN.N-acetylcysteine fails to prevent renal dysfunction and oxidative stress after noniodine contrast media administration during percutaneous coronary interventions201012010383389CamposC.GuzmánR.López-FernándezE.CasadoÁ.Urinary biomarkers of oxidative/nitrosative stress in healthy smokers201123314815610.3109/08958378.2011.5544602-s2.0-79952612331CamposC.GuzmánR.López-FernándezE.CasadoÁ.Urinary uric acid and antioxidant capacity in children and adults with Down syndrome201043322823310.1016/j.clinbiochem.2009.09.0172-s2.0-74249096152CaoG.RussellR. M.LischnerN.PriorR. L.Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women199812812238323902-s2.0-0032435412ChienJ.-W.WangL.-Y.ChengY.-S.TsaiY.-G.LiuC.-S.Urinary 8-hydroxy-2′-deoxyguanosine (8-oxodG) level can predict acute renal damage in young children with urinary tract infection201419432633110.3109/1354750x.2014.9105522-s2.0-84901316900CiftciH.VeritA.YeniE.SavasM.Decreased oxidative stress index of urine in patients with urinary tract infection200881331231510.1159/0001514102-s2.0-54249112844DamodaranL. P. M.ArumugamG.Urinary oxidative stress markers in children with autism201116521622210.1179/1351000211y.00000000122-s2.0-80053907390Dos Santos MelloM.RibasG. S.WayhsC. A. Y.HammerschmidtT.GuerreiroG. B. B.FavenzaniJ. L.SittaÂ.De Moura CoelhoD.WajnerM.VargasC. R.Increased oxidative stress in patients with 3-hydroxy-3-methylglutaric aciduria20154021-214915510.1007/s11010-014-2322-x2-s2.0-84920517485EomS.-Y.YimD.-H.MoonS. I.YounJ.-W.KwonH.-J.OhH. C.YangJ. J.ParkS. K.YooK.-Y.KimH. S.LeeK.-S.ChangS.-H.KimY.-D.KangJ.-W.KimH.Polycyclic aromatic hydrocarbon-induced oxidative stress, antioxidant capacity, and the risk of lung cancer: a pilot nested case-control study2013338308930972-s2.0-84883271592GarridoM.ParedesS. D.CuberoJ.LozanoM.Toribio-DelgadoA. F.MuñozJ. L.ReiterR. J.BarrigaC.RodríguezA. B.Jerte valley cherry-enriched diets improve nocturnal rest and increase 6-sulfatoxymelatonin and total antioxidant capacity in the urine of middle-aged and elderly humans201065990991410.1093/gerona/glq0992-s2.0-77955882733GöknarN.OktemF.AriE.DemirA. D.TorunE.Is oxidative stress related to childhood urolithiasis?20142981381138610.1007/s00467-014-2773-z2-s2.0-84903764448González-FloresD.GameroE.GarridoM.RamírezR.MorenoD.DelgadoJ.ValdésE.BarrigaC.RodríguezA. B.ParedesS. D.Urinary 6-sulfatoxymelatonin and total antioxidant capacity increase after the intake of a grape juice cv. Tempranillo stabilized with HHP201231343910.1039/c1fo10146c2-s2.0-84855389060GuerreiroG.MesckaC. P.SittaA.DonidaB.MarchettiD.HammerschmidtT.FaverzaniJ.de Moura CoelhoD.WajnerM.Dutra-FilhoC. S.VargasC. R.Urinary biomarkers of oxidative damage in Maple syrup urine disease: the l-carnitine role201542101410.1016/j.ijdevneu.2015.02.003HassimottoN. M. A.PintoM. D. S.LajoloF. M.Antioxidant status in humans after consumption of blackberry (Rubus fruticosus L.) juices with and without defatted milk20085624117271173310.1021/jf80261492-s2.0-58849118562HatipoğluN. K.EvliyaoğluO.IşikB.BodakçiM. N.BozkurtY.SancaktutarA. A.SöylemezH.AtarM.PenbegülN.YünceM.DağgulliM.Antioxidant signal and kidney injury molecule-1 levels in shockwave lithotripsy induced kidney injury201428222422810.1089/end.2013.05352-s2.0-84893469539HelbigD.WagnerA.SchubertR.JahreisG.Tocopherol isomer pattern in serum and stool of human following consumption of black currant seed press residue administered in whole grain bread200928666266710.1016/j.clnu.2009.05.0032-s2.0-71549142260HudthagosolC.HaddadE.JongsuwatR.Antioxidant activity comparison of walnuts and fatty fish201295supplement 6S179S1882-s2.0-84871854867JacobK.PeriagoM. J.BöhmV.BerruezoG. R.Influence of lycopene and vitamin C from tomato juice on biomarkers of oxidative stress and inflammation200899113714610.1017/S00071145077918942-s2.0-37349100544KirschbaumB.Total urine antioxidant capacity20013051-216717310.1016/s0009-8981(01)00381-32-s2.0-0035102489Mc GuireP. J.ParikhA.DiazG. A.Profiling of oxidative stress in patients with inborn errors of metabolism2009981-217318010.1016/j.ymgme.2009.06.0072-s2.0-67749117788MiglioC.PelusoI.RaguzziniA.VillañoD. V.CesquiE.CatastaG.TotiE.SerafiniM.Fruit juice drinks prevent endogenous antioxidant response to high-fat meal ingestion2014111229430010.1017/S00071145130024072-s2.0-84896600227PatchsungM.BoonlaC.AmnattrakulP.DissayabutraT.MutiranguraA.TosukhowongP.Long interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential201275e3700910.1371/journal.pone.00370092-s2.0-84866493708PfundsteinB.HaubnerR.WürteleG.GehresN.UlrichC. M.OwenR. W.Pilot walnut intervention study of urolithin bioavailability in human volunteers20146242102641027310.1021/jf50406522-s2.0-84908374936RanjbarA.RashediV.RezaeiM.Comparison of urinary oxidative biomarkers in Iranian children with autism201435112751275510.1016/j.ridd.2014.07.0102-s2.0-84905216516Revuelta-IniestaR.Al-DujailiE. A. S.Consumption of green coffee reduces blood pressure and body composition by influencing 11β-HSD1 enzyme activity in healthy individuals: a pilot crossover study using green and black coffee20142014948270410.1155/2014/482704RibasG. S.BianciniG. B.MesckaC.WayhsC. Y.SittaA.WajnerM.VargasC. R.Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation2012321778210.1007/s10571-011-9736-82-s2.0-84856553552RouraE.AlmajanoM. P.BilbaoM. L. M.Andrés-LacuevaC.EstruchR.Lamuela-RaventósR. M.Human urine: epicatechin metabolites and antioxidant activity after cocoa beverage intake200741894394910.1080/107157607014352362-s2.0-34547494926SchmidtM. C.AskewE. W.RobertsD. E.PriorR. L.EnsignW. Y.Jr.HesslinkR. E.Jr.Oxidative stress in humans training in a cold, moderate altitude environment and their response to a phytochemical antioxidant supplement20021329410510.1580/1080-6032(2002)013[0094:OSIHTI]2.0.CO;22-s2.0-0036082004ShermatovK.ZeyrekD.YildirimF.KilicM.CebiN.KocyigitA.DNA damage in children exposed to secondhand cigarette smoke and its association with oxidative stress2012491295896210.1007/s13312-012-0250-y2-s2.0-84874416549ShoskesD. A.ShahedA. R.KimS.GritschH. A.DanovitchG.WilkinsonA.Oxidant stress and antioxidant capacity in urine of renal transplant recipients predict early graft function2001331-298410.1016/s0041-1345(00)02297-12-s2.0-0035087145ShoskesD. A.WebsterR.ShahedA.Oxidant stress in cadaveric and living kidney donors as markers of renal injury: utility of total antioxidant capacity and isoprostane levels in urine200032480480510.1016/s0041-1345(00)00991-x2-s2.0-0034036885SillimanK.ParryJ.KirkL. L.PriorR. L.Pycnogenol does not impact the antioxidant or vitamin C status of healthy young adults20031031677210.1053/jada.2003.50042-s2.0-0037263824StewartR. J.AskewE. W.McDonaldC. M.MetosJ.JacksonW. D.BalonT. W.PriorR. L.Antioxidant status of young children: response to an antioxidant supplement2002102111652165710.1016/s0002-8223(02)90352-42-s2.0-0036835740Wachtel-GalorS.SzetoY.-T.TomlinsonB.BenzieI. F. F.Ganoderma lucidum (‘Lingzhi’); acute and short-term biomarker response to supplementation2004551758310.1080/096374803100016425102-s2.0-0942277178Wachtel-GalorS.TomlinsonB.BenzieI. F. F.Ganoderma lucidum (‘Lingzhi’), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study200491226326910.1079/bjn200410392-s2.0-1342282406YilmazE.HaciislamogluA.KisaU.DoganO.YuvancE.BatislamE.Ways in which SWL affects oxidant/antioxidant balance201341213714110.1007/s00240-012-0537-42-s2.0-84880918222LiuZ.LiuY.SongY.ZhangX.WangS.WangZ.Systemic oxidative stress biomarkers in chronic periodontitis: a meta-analysis201420141093108310.1155/2014/9310832-s2.0-84919372451BhangooR. S.HallI. E.ReeseP. P.ParikhC. R.Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes: a systematic review20122783305331410.1093/ndt/gfr8062-s2.0-84864614153BonominiF.RodellaL. F.RezzaniR.Metabolic syndrome, aging and involvement of oxidative stress20156210912010.14336/ad.2014.0305TaeW. Y.KiC. S.HunS. S.ByungJ. K.BumS. K.JinH. K.ManH. L.JungR. P.KimH.EunJ. R.WonY. L.SunW. K.SeungH. R.DongG. K.Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome200569892893310.1253/circj.69.9282-s2.0-23744441488KleinB. E. K.KleinR.LeeK. E.Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam200225101790179410.2337/diacare.25.10.17902-s2.0-0036783236KawamotoR.TomitaH.OkaY.OhtsukaN.Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis200645960561410.2169/internalmedicine.45.16612-s2.0-33745068714SerafiniM.MiglioC.PelusoI.PetrosinoT.Modulation of plasma non enzimatic antioxidant capacity (NEAC) by plant foods: the role of polyphenols201111141821184610.2174/1568026117962351252-s2.0-79959930134VegliaF.CighettiG.De FranceschiM.ZingaroL.BoccottiL.TremoliE.CavalcaV.Age- and gender-related oxidative status determined in healthy subjects by means of OXY-SCORE, a potential new comprehensive index200611656257310.1080/135475006008986232-s2.0-33750338702KamodyováN.CelecP.Salivary markers of oxidative stress and Salivette collection systems201149111887189010.1515/CCLM.2011.6772-s2.0-80755171201NeyraudE.PalickiO.SchwartzC.NicklausS.FeronG.Variability of human saliva composition: possible relationships with fat perception and liking201257555656610.1016/j.archoralbio.2011.09.0162-s2.0-84860219397NaglerR. M.KleinI.ZarzhevskyN.DriguesN.ReznickA. Z.Characterization of the differentiated antioxidant profile of human saliva200232326827710.1016/S0891-5849(01)00806-12-s2.0-0036468863GunnI. R.Biological variation of serum and urine creatinine and creatinine clearance198926part 33023032-s2.0-0024659755GhiselliA.SerafiniM.MaianiG.AzziniE.Ferro-LuzziA.A fluorescence-based method for measuring total plasma antioxidant capability1995181293610.1016/0891-5849(94)00102-p2-s2.0-0028814737BenzieI. F. F.StrainJ. J.The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay19962391707610.1006/abio.1996.02922-s2.0-0030586361LissiE.Salim-HannaM.PascualC.del CastilloM. D.Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements199518215315810.1016/0891-5849(94)00117-32-s2.0-0028837204EmmersonB. T.The management of gout1996334744545110.1056/nejm1996021533407072-s2.0-0030584230MesserliF. H.FrohlichE. D.DreslinskiG. R.SuarezD. H.AristimunoG. G.Serum uric acid in essential hypertension: an indicator of renal vascular involvement198093681782110.7326/0003-4819-93-6-8172-s2.0-0019202531Quiñones GalvanA.NataliA.BaldiS.FrascerraS.SannaG.CiociaroD.FerranniniE.Effect of insulin on uric acid excretion in humans1995268E1E5DuplancicD.Kukoc-ModunL.ModunD.RadicN.Simple and rapid method for the determination of uric acid-independent antioxidant capacity20111687058706710.3390/molecules160870582-s2.0-80052189146MalliarakiN.MpliampliasD.KampaM.PerakisK.MargiorisA. N.CastanasE.Total and corrected antioxidant capacity in hemodialyzed patients20034, article 410.1186/1471-2369-4-42-s2.0-2942726296BentleyR.NeubergerA.The mechanism of the action of uricase195252469469910.1042/bj05206942-s2.0-0007309382